Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Ultragenyx Pharmaceutical Inc    RARE

ULTRAGENYX PHARMACEUTICAL INC

(RARE)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on ULTRAGENYX PHARMACEUTICAL
06/11/19 | 05:00pm Annual General Meeting
08/05/19 Interim 2019 Earnings Release (Projected)
11/11/19 Q3 2019 Earnings Release (Projected)
02/18/20 FY 2019 Earnings Release (Projected)
Past events on ULTRAGENYX PHARMACEUTICAL
05/14/19 | 06:40pm Bank of America Merrill Lynch Health Care Conference
05/14/19 MIXiii-BIOMED Conference
05/06/19 | 05:00pm Q1 2019 Earnings Call
05/06/19 | 04:01pm Q1 2019 Earnings Release
Upcoming sector events for ULTRAGENYX PHARMACEUTICAL
05/21/19 | 10:30am INCYTE CORPORATION : RBC Capital Markets Healthcare Conference
05/21/19 | 02:00pm EXACT SCIENCES CORPORATION : UBS Global Healthcare Conference
05/21/19 | 03:05pm EXELIXIS, INC. : RBC Capital Markets Healthcare Conference
05/21/19 | 03:35pm SAGE THERAPEUTICS INC : RBC Capital Markets Healthcare Conference
More events
Past sector events for ULTRAGENYX PHARMACEUTICAL
05/20/19 GENMAB A/S : UBS Global Healthcare Conference
05/20/19 | 02:00pm SEATTLE GENETICS, INC. : Annual General Meeting
05/20/19 | 03:00pm INCYTE CORPORATION : UBS Global Healthcare Conference
05/20/19 | 09:30pm SHANGHAI RAAS BLOOD PRODUCTS CO., LTD. : Annual General Meeting
Annual publications
Previous yearNext Year
Annual results2016201720182019 (e)2020 (e)
Sales
Million $
Released
Forecast
Spread
0,13
1,07
-88%
2,61
0,43
501%
51,5
49,3
4,4%

97,3

211
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-245
-239
-2,4%
-323
-319
-1,4%
-352
-363
3,0%

-386

-257
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-248
-245
-1,3%
-329
-318
-3,3%
-371
-376
1,1%

-387

-284
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-246
-244
-0,80%
-318
-308
-3,5%
-197
-202
2,2%

-376

-282
Net income
Million $
Released
Forecast
Spread
-246
-244
-0,82%
-302
-299
-1,0%
-198
-201
1,7%

-377

-281
EPS
 $
Released
Forecast
Spread
-6,21
-6,19
-0,36%
-7,12
-7,03
-1,3%
-3,97
-3,98
0,37%

-6,92

-4,82
Announcement Date02/16/201702/20/201802/19/2019

Quarterly / Semiannualy publications
Previous yearPrevious periodNext periodNext Year
Quarterly resultsQ3
2018
Q4
2018
Q1
2019
Q2
2019 (e)
Q3
2019 (e)
Sales
Million $
Released
Forecast
Spread
11,8
11,4
3,6%
16,3
13,7
19%
18,2
18,3
-0,68%

22,1

26,5
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-85,3
-95,4
11%
-87,4
-92,5
5,6%






Operating profit (EBIT)
Million $
Released
Forecast
Spread
-89,6
-100
11%
-90,3
-93,4
3,2%
-99,2
-92,1
-7,7%

-98,2

-95,6
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-87,1
-99,6
13%
-87,7
-91,3
4,0%
-96,5
-90,7
-6,5%

-96,2

-93,5
Net income
Million $
Released
Forecast
Spread
-87,3
-98,8
12%
-87,8
-91,4
3,9%
-96,8
-90,7
-6,7%

-96,2

-93,5
EPS
 $
Released
Forecast
Spread
-1,74
-1,96
11%
-1,73
-1,79
3,3%
-1,82
-1,78
-2,4%

-1,74

-1,71
Announcement Date11/05/201802/19/201905/06/2019

© 2019 Thomson Reuters
© 2019 Factset
Operating profit (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
Operating profit (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise